Essure (Model ESS310) Placement Rate Study
NCT02064413 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 134
Last updated 2021-04-08
Summary
To evaluate the safety and successful placement rate of Essure Model ESS310 device and any factors that may influence the successful placement rate of this device.
Conditions
- Contraception
Interventions
- DEVICE
-
ESS310 (BAY1454032)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Max Age
- 44 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-17
- Primary Completion
- 2014-10-02
- Completion
- 2014-11-26
Countries
- United States
Study Locations
More Related Trials
-
Simplified IUD Insertion Technique
NCT02733081 ·Status: WITHDRAWN ·Phase: NA
-
FemBloc® Permanent Contraception - Confirmation Feasibility Trial
NCT04273594 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Assessment of the INVOcell Culture Device When Used for up to Five-Day Incubation
NCT04644380 ·Status: COMPLETED ·Phase: NA
-
BioWick SureLock Clinical Outcomes Study
NCT03199391 ·Status: COMPLETED ·Phase: NA
-
Non Touch Technique for IUD Insertion
NCT02582281 ·Status: UNKNOWN ·Phase: NA
-
A Study of Different Injectable Formulations of LY3375880 in Healthy Participants
NCT03913260 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Pain and Effectiveness of Carevix Device for IUD Insertions
NCT07290517 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sorrel 25R Injector - Sorrel Clinical Study Protocol
NCT05221333 ·Status: UNKNOWN ·Phase: NA
-
Usability, Safety and Efficacy of AspivixTM (Comparative Study)
NCT04441281 ·Status: COMPLETED ·Phase: NA
-
Novel Cervical Retraction Device
NCT02283463 ·Status: UNKNOWN ·Phase: NA
-
Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures
NCT06193590 ·Status: COMPLETED ·Phase: NA
-
Preliminary Evaluation of a "Clip" Device for Contraceptive Implant Removal
NCT04919395 ·Status: TERMINATED ·Phase: NA
-
Intrauterine Device (IUD) Self Removal
NCT05191238 ·Status: TERMINATED ·Phase: NA
-
Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2
NCT00780286 ·Status: COMPLETED ·Phase: PHASE1
-
AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)
NCT04663867 ·Status: COMPLETED ·Phase: NA
-
BD MiniDraw™ Capillary System Clinical Equivalence Study
NCT05186311 ·Status: COMPLETED
-
RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
NCT02175030 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of New Single-use Compact Intermittent Catheter
NCT05841004 ·Status: COMPLETED ·Phase: NA
-
Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen
NCT01879319 ·Status: COMPLETED ·Phase: PHASE3
-
Béa Applicator and Béa Cervical Cap Safety and Usability Study
NCT05129553 ·Status: UNKNOWN ·Phase: NA
-
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
NCT06693011 ·Status: RECRUITING ·Phase: NA
-
Allis Clamp Versus Single-tooth Tenaculum
NCT05187078 ·Status: COMPLETED ·Phase: NA
-
Long-Term Assessment of the Safety and Performance of the NuVasive Simplify Disc at Two Levels
NCT05691231 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of the Biocompatibility of Cartridge Blood Set Versus Standard Blood Line
NCT00804453 ·Status: COMPLETED ·Phase: NA
-
An Investigation to Evaluate Wearing Properties of Three Different Investigational Devices
NCT07034014 ·Status: RECRUITING ·Phase: NA